Dr. Sandra Sanchez-Roige explains how large-scale studies of genome variations have identified risk locations for substance use disorders. She also discusses the importance of converting these signals from the genome into biological understanding of mechanisms and vulnerabilities which may provide a path forward for the development of novel treatments.
Read More
Dr. Volkow, Director of the National Institute on Drug Abuse (NIDA) and leading authority on substance use and the science of addiction, explains the origins of the fentanyl crisis, the challenges of treating overdoses, and offers her assessment of psychedelics as therapies for psychiatric illness, as well as current evidence on the dangers of regular cannabis use among young people.
Read More
Dr. Sarah Lisanby has been deeply involved in developing and improving the safety of life-saving neuromodulatory treatments including electroconvulsive therapy (ECT) and magnetic seizure therapy (MST) for severe psychiatric illness.
Read More
We are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.
Read More
Dr. Jeffrey Borenstein interviews Dr. Joan Luby of Washington University, St. Louis, whose research has changed views on the subject.
Read More